In the last trading session, 1.9 million ReShape Lifesciences Inc (NASDAQ:RSLS) shares changed hands as the company’s beta touched 1.47. With the company’s per share price at $0.36 changed hands at -$0.01 or -0.85% during last session, the market valuation stood at $4.09M. RSLS’s last price was a discount, traded about -7955.56% off its 52-week high of $29.00. The share price had its 52-week low at $0.30, which suggests the last value was 16.67% up since then. When we look at ReShape Lifesciences Inc’s average trading volume, we note the 10-day average is 18.41 million shares, with the 3-month average coming to 15.40 million.
Analysts gave the ReShape Lifesciences Inc (RSLS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended RSLS as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. ReShape Lifesciences Inc’s EPS for the current quarter is expected to be 0.
ReShape Lifesciences Inc (NASDAQ:RSLS) trade information
Instantly RSLS was in red as seen at the end of in last trading. With action -5.56%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -91.89%, with the 5-day performance at -5.56% in the red. However, in the 30-day time frame, ReShape Lifesciences Inc (NASDAQ:RSLS) is -17.84% down. Looking at the short shares, we see there were 1.04 million shares sold at short interest cover period of 0.03 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 80.05%.
RSLS Dividends
ReShape Lifesciences Inc is expected to release its next quarterly earnings report on 2025-Apr-03.
ReShape Lifesciences Inc (NASDAQ:RSLS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 4.11% of ReShape Lifesciences Inc shares while 4.88% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 5.09%.
Among Mutual Funds, the top two as of Jan 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 2.39 shares estimated at $865.0 under it, the former controlled 0.02% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.01% of the shares, roughly 860.0 shares worth around $311.0.
